Acutely dysregulated, chronically disabled by the enemy within: T-cell responses to HIV-1 infection

被引:38
|
作者
Munier, M. L.
Kelleher, A. D.
机构
[1] Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Darlinghurst, NSW 2010, Australia
[2] St Vincents Hosp, Ctr Immunol, Sydney, NSW 2010, Australia
来源
IMMUNOLOGY AND CELL BIOLOGY | 2007年 / 85卷 / 01期
关键词
AIDS; human immunodeficiency virus; immunity cellular; T cell; HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; IMMUNE RESTORATION DISEASE; STRUCTURED TREATMENT INTERRUPTION; RECEPTOR EXCISION CIRCLES; TH1; EFFECTOR-CELLS; PERIPHERAL-BLOOD; CD4(+) CELLS; LYMPHOID-TISSUES; TYPE-1; INFECTION;
D O I
10.1038/sj.icb.7100015
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Human immunodeficiency virus (HIV) infection causes chronic progressive immunodeficiency and immune dysregulaton. Although simple depletion of the major target of HIV infection, the CD4+ T cell, can explain much of the immunosuppression seen, there are multiple other factors contributing to the immune dysiregulation. CD4+ T-cell depletion induces a range of homeostatic mechanisms that contribute to immune activation and cell turnover, providing a milieu conducive to further viral replication and cell destruction, resulting in functional defects in various lymphoid organs. These changes are progressive and in turn compromise the homeostatic processes. Further, the infection, like any other viral infection, provokes an active immune response consisting of both CD4+ and CD8+ T-cell responses. Both appear compromised, displaying aberrant memory cell production. While some of these defects result from viral variation and the chronicity of antigen presentation, other defects of memory cell production appear very early during the primary immune response limiting the viral specific T-cell responses from the outset. This, combined with the ability of the virus to escape any successful immune responses, results in an attenuated immune response that eventually becomes exhausted, characterized by progressive deficits in T-cell repertoire. Furthermore, negative regulatory mechanisms that normally control the immune response may be aberrantly invoked, perhaps directly by the virus, further compromising the efficacy of the immune response. Rational design of effective immunotherapies depends on a clear understanding of the processes compromising the immune response to HIV.
引用
收藏
页码:6 / 15
页数:10
相关论文
共 50 条
  • [41] Regulatory B cells are induced in untreated HIV-1 infection and suppress HIV-1 specific T cell responses
    J Liu
    W Zhan
    C Kim
    E Lee
    J Cao
    B Ziegler
    A Gregor
    F Yue
    S Huibner
    S Macparland
    K Clayton
    J Schwartz
    H Song
    E Bento
    C Kovacs
    R Kaul
    M Ostrowski
    Retrovirology, 9
  • [42] STUDIES ON V3-SPECIFIC CROSS-REACTIVE T-CELL RESPONSES IN CHIMPANZEES CHRONICALLY INFECTED WITH HIV-1(IIIB)
    NEHETE, PN
    MURTHY, KK
    SATTERFIELD, WC
    ARLINGHAUS, RB
    SASTRY, KJ
    AIDS, 1995, 9 (06) : 567 - 572
  • [43] Regulatory B cells are induced in untreated HIV-1 infection and suppress HIV-1 specific T cell responses
    Liu, J.
    Zhan, W.
    Kim, C.
    Lee, E.
    Cao, J.
    Ziegler, B.
    Gregor, A.
    Yue, F.
    Huibner, S.
    Macparland, S.
    Clayton, K.
    Schwartz, J.
    Song, H.
    Bento, E.
    Kovacs, C.
    Kaul, R.
    Ostrowski, M.
    RETROVIROLOGY, 2012, 9
  • [44] Characterization of HIV-1 Gag-specific T cell responses in chronically infected indian population
    Kaushik, S
    Vajpayee, M
    Wig, N
    Seth, P
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2005, 142 (02): : 388 - 397
  • [45] Antibody B cell responses in HIV-1 infection
    Mouquet, Hugo
    TRENDS IN IMMUNOLOGY, 2014, 35 (11) : 549 - 561
  • [46] EVALUATION OF CYTOTOXIC T-CELL RESPONSES TO CANDIDATE HIV-1 VACCINES IN HIV-1-UNINFECTED INDIVIDUALS
    MCELRATH, MJ
    COREY, L
    GREENBERG, PD
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 : S69 - S72
  • [47] HIV-1 gp120 T-Cell Responses Correspond to Infection Outcomes in the Global iPrEx Chemoprophylaxis Trial
    Kuebler, Peter J.
    Shaw, Brian I.
    Leadabrand, Kaitlyn S.
    Mehrotra, Megha L.
    Grant, Robert M.
    Kallas, Esper G.
    Nixon, Douglas F.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 72 (02) : 184 - 188
  • [48] CD8 T-cell responses in early HIV-1 infection are skewed towards high entropy peptides
    Bansal, A
    Gough, E
    Sabbaj, S
    Ritter, D
    Yusim, K
    Sfakianos, G
    Aldrovandi, G
    Kaslow, RA
    Wilson, CM
    Mulligan, MJ
    Kilby, JM
    Goepfert, PA
    AIDS, 2005, 19 (03) : 241 - 250
  • [49] γδ T-cell responses during HIV infection and antiretroviral therapy
    Juno, Jennifer A.
    Eriksson, Emily M.
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2019, 8 (07)
  • [50] Alpha-momorcharin inhibits HIV-1 replication in acutely but not chronically infected T-lymphocytes
    Zheng, YT
    Ben, KL
    Jin, SW
    ACTA PHARMACOLOGICA SINICA, 1999, 20 (03): : 239 - 243